Erythropoietin receptor agonist

This page covers all Erythropoietin receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Erythropoietin receptor (EPOR), Erythropoietin receptor.

Targets

Erythropoietin receptor (EPOR) · Erythropoietin receptor

Phase 3 pipeline (4)

• LA-EP2006 · Sandoz · Hematology
  LA-EP2006 is a long-acting recombinant human erythropoietin (EPO) analog that stimulates red blood cell production by binding to and activating the erythropoietin receptor.
• GerEPO · Ministry of Health, Malaysia · Hematology
  GerEPO is an erythropoietin (EPO) analog that stimulates red blood cell production by binding to the erythropoietin receptor on bone marrow progenitor cells.
• Open-label rusfertide · Protagonist Therapeutics, Inc. · Nephrology
  Rusfertide is a human erythropoietin receptor agonist.
• EPORON · Dong-A ST Co., Ltd. · Hematology/Oncology
  EPORON is an erythropoietin (EPO) receptor agonist that stimulates red blood cell production to treat anemia.